Current evidence, including position statements from major headache societies and prospective clinical studies, demonstrates that telemedicine is a safe, effective, and well-accepted modality for the clinical management and follow-up of migraine and other headache disorders.
The retrieved literature contains specific, high-quality guidelines and studies (such as the American Headache Society position statement and clinical follow-up studies) specifically addressing telemedicine for headache and migraine care. These sources consistently support its safety, efficacy, and high patient satisfaction without counter-evidence refuting its effectiveness in this domain.